Aurobindo Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma's promoters, led by K. Nithyananda Reddy, have filed their annual declaration under SEBI's Takeover Regulations stating that they have not created any new encumbrances (such as pledges or liens) on their shares during the financial year ending March 31, 2025, beyond what was already disclosed earlier. The filing includes a detailed list of all 15 promoter and promoter group entities along with their individual shareholdings. Together, the promoter and promoter group hold 30.09 crore shares, which is 51.82% of the company's total share capital. The largest single holder is RPR Sons Advisors Pvt Ltd (jointly with P. Suneela Rani) at 33.50%, followed by K. Nithyananda Reddy at 4.37% and Kirthi Reddy Kambam at 3.45%.
This is a routine annual compliance filing and does not indicate any change in promoter holdings or new risk to shareholders. The promoter group continues to hold a comfortable majority of 51.82%, with no fresh pledging of shares, which is a neutral-to-positive signal regarding promoter financial standing.